Moving Research into Practice
You’ve worked hard to develop your prognostic models & decision support tools that seek to impact clinical care.
Let QxMD help make your work available to the world, at the moment of publication, on our digital platform that includes iOS, Android and web.
What We Offer
We take predictive models, decision support tools, consensus guidelines, diagnostic tools and treatment algorithms and convert them into practical handheld tools. We work with iPhone, iPad, Android smartphones & tablets and any web-enabled device (including desktops).
A Simple Process
Tell Us About Your Work
Explain why your research matters and the goals of your work.
Complete a Submission Template
Fill out a brief submission form so our development team can get to work.
Test what we build and let us know how we can optimize it further.
We flip the switch and make your work available to the 400K healthcare professionals on the QxMD platform each month.
While we’ve collaborated with countless researchers, here are a few projects that were particularly notable.
The CLL-IPI is the result of an international collaboration led by Dr. Michael Hallek, chair of the German CLL study group. The index was developed in ~3500 patients participating in phase 3 trials from around the world and was subsequently independently validated in cohorts of newly diagnosed patients from Mayo Clinic and the Swedish CLL Database.
The tool was originally reported at ASCO. When plans were made to publish the full results in Lancet-Oncology, the QxMD team was brought in to adapt the tool for web and mobile devices.
Since that time, the prognostic tool has been further validated and sees widespread global adoption.
Vascular Quality Initiative Cardiac Risk Index
Kidney Failure Risk Equation
In hopes of rapidly pushing new knowledge into clinical practice, QxMD collaborated with JAMA and Dr Navdeep Tangri’s research team to launch the Kidney Failure Risk Equation at the same time the study lead presented the evidence at the World Congress of Nephrology
The tool was designed to help clinicians determine the risk of renal failure and the need for dialysis in patients with chronic kidney disease. At the time of his presentation, JAMA published the paper online and QxMD released an update to Calculate by QxMD to include the model.
‘Calculate by QxMD’ allowed us to translate the knowledge from our model on Day 1. In an era where bench to bedside translation can take more than a decade, this kind of collaboration can greatly accelerate the knowledge to action cycle.Navdeep Tangri, MD, PhD
The Vascular Quality Initiative has found QxCalculate an extremely effective way empower physicians and health care providers to employ evidence based medicine in the care of their vascular patients.Daniel J Bertges, MD, FACS
An online app makes new clinical tools relevant and readily available. QxMD provides a service for investigators that allows new clinical tools to be available at the time of publication. This allows the reader of new research papers to more clearly understand the findings. This allows the clinician to use new clinical tools as soon as they have been published.Andrew Rule, MD
Try Calculate by QxMD for FREE
The best way to understand how Calculate makes research easy to apply at the point of care